Login
$SKYE
$1.45 -$0.12 (7.64%) Close

Company Executives

Officer Age In this role Joined 2025 pay Source
Punit Dhillon Also a director
President and Chief Executive Officer
45 Not stated Not stated $1,361,831
John P. Sharp
Chief Financial Officer
61 Since 2026
this year
Not stated Not reported
Tu Diep
Chief Operating Officer
45 Since 2025
1 year
Not stated $875,939
Chris Twitty
Chief Scientific Officer
54 Since 2022
4 years
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
6
serving now
Independent
0 of 2
stated in the proxy; 4 not stated
Average tenure
3.5 years
from year joined
CEO also chairs the board
No
Paul Grayson
Director Age On board Independent Committees Other public boards 2025 pay Source
Paul Grayson
61 2023
3 years
Not stated
Audit Committee Compensation Committee
None stated $369,358
Punit Dhillon
45 2018
8 years
Not independent None stated None stated Paid as CEO
Deborah Charych
62 2023
3 years
Not stated None stated None stated $116,940
Annalisa Jenkins
60 2024
2 years
Not stated None stated Affimed GmbH, Mereo BioPharma Group plc, Compass Pathways PLC $133,815
Karen Smith
58 2024
2 years
Not stated None stated None stated $131,940
Andrew J. Schwab
55 2023
3 years
Not independent None stated None stated $109,440

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

3 disclosed in the proxy filed Apr 16, 2026
5AM Ventures VII, L.P.
a preexisting stockholder who, together with other affiliated entities, beneficially owned in excess of 5% of our issued and outstanding shares of common stock
Amount not stated
2024

Purchased 5,206,074 shares of common stock in the January 2024 PIPE Financing.

With the Company Open in proxy
5AM Ventures VII, L.P.
a preexisting stockholder who, together with other affiliated entities, beneficially owned in excess of 5% of our issued and outstanding shares of common stock
Amount not stated
2024

Purchased 450,000 shares of common stock in the March 2024 PIPE Financing.

With the Company Open in proxy
5AM Ventures VII, L.P.
a preexisting stockholder who, together with other affiliated entities, beneficially owned in excess of 5% of our issued and outstanding shares of common stock
Amount not stated
2024

Company amended the 2023 PIPE Warrants held by 5AM Ventures VII, L.P. to allow cashless exercise under specified conditions.

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support